Key result
Programmed ventricular stimulation guides sudden cardiac death risk stratification in acquired and inherited cardiac diseases.
Why the study?
The ability of non-invasive arrhythmic risk indexes to stratify SCD risk among asymptomatic patients with cardiac disease remains debated.
Does programmed ventricular stimulation (PVS) improve sudden cardiac death (SCD) risk stratification in patients with acquired or inherited cardiac disease?
Does programmed ventricular stimulation (PVS) improve sudden cardiac death (SCD) risk stratification in patients with acquired or inherited cardiac disease?
This review summarizes the prognostic role of programmed ventricular stimulation for sudden cardiac death risk stratification across various clinical settings.
Answers are grounded in this paper and cite their sources.
Supports PVS for SCD risk stratification across cardiac diseases; leaves open need for prospective validation and guideline integration.
Sudden cardiac death (SCD) is one of the leading causes of cardiovascular death in general population. SCD primary prevention requires the correct selection of patients at increased risk who may benefit from implantable cardioverter-defibrillator (ICD). Despite several non-invasive arrhythmic risk indexes are available, their ability to stratify the SCD risk among asymptomatic patients with cardiac disease at increased arrhythmic risk is debated. The programmed ventricular stimulation (PVS) is an invasive approach historically used for SCD risk stratification in patients with acquired or inherited cardiac disease and is currently included in international guidelines. Aim of this review is to summarize all available data about the role of PVS for the SCD risk stratification in different clinical settings.
No takes yet. Share an insight, caveat, or question.
Iavarone et al. (2023) conducted a review in Sudden cardiac death. Programmed ventricular stimulation was evaluated. Programmed ventricular stimulation serves as an invasive approach for sudden cardiac death risk stratification in patients with acquired or inherited cardiac disease across different clinical settings.
Synapse has enriched 10 related papers. Consider them for comparative context: